Fig. 1From: Recurrent severe hypocalcemia following chemotherapy regimen changes in advanced breast cancer: two case reportsChemotherapy regimens and trends of serum calcium (uncorrected) in case 1. Severe hypocalcemia recurred on the 99th day of tegafur/gimeracil/oteracil therapy and on the 22nd day of eribulin therapy. Despite the necessity of calcium supplementation, eribulin was continued at a lower dosageBack to article page